Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression
Introduction: One of the most pressing goals for cancer immunotherapy at this time is the identification of actionable antigens. Methods: This study relies on the following considerations and approaches to identify potential breast cancer antigens: (i) the significant role of the adaptive immune rec...
Main Authors: | Nagehan Pakasticali, Andrea Chobrutskiy, Dhruv N. Patel, Monica Hsiang, Saif Zaman, Konrad J. Cios, George Blanck, Boris I. Chobrutskiy |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-05-01
|
Series: | Cancer Informatics |
Online Access: | https://doi.org/10.1177/11769351231177269 |
Similar Items
-
Erratum to “Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression”
Published: (2023-07-01) -
Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression
by: Miguel A. Arias, et al.
Published: (2023-04-01) -
The Expansion of the Spectrum in Stuttering Disorders to a Novel ARMC Gene Family (<i>ARMC3</i>)
by: Adil U Rehman, et al.
Published: (2022-12-01) -
Granzymes—Their Role in Colorectal Cancer
by: Sara Pączek, et al.
Published: (2022-05-01) -
ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors
by: Yosuke Okuno, et al.
Published: (2022-08-01)